What diseases cause degeneration or loss of nerve cells in the brain?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 18, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Neurodegenerative Diseases Causing Degeneration or Loss of Nerve Cells in the Brain

Alzheimer's, Parkinson's, and Huntington's diseases are the neurodegenerative disorders that cause degeneration or loss of nerve cells in the brain. 1

Characteristics of Neurodegenerative Diseases

Neurodegenerative diseases comprise a spectrum of heterogeneous pathologies characterized by:

  • Progressive dysfunction, degeneration, and death of neurons
  • Incurable and debilitating conditions
  • Age-related onset (typically after 40 years)
  • Gradual progression of symptoms

Common Pathological Mechanisms

These diseases share several molecular and cellular pathologies:

  • Mitochondrial dysfunction
  • Protein aggregation
  • Glutamate toxicity
  • Calcium load
  • Proteolytic stress
  • Oxidative stress
  • Neuroinflammation
  • Aging-related processes 2

Specific Neurodegenerative Diseases

Alzheimer's Disease

  • Characterized by impaired activity of respiratory chain Complex IV 1
  • Shows hypometabolism in the medial frontal and anterior cingulate cortices
  • Progressive loss of neurons in the cortex, hippocampus, and basal forebrain
  • Development of neurofibrillary tangles and senile plaques 3
  • Manifests as progressive cognitive decline and memory impairment 1

Parkinson's Disease

  • Characterized by reduced expression and impaired activity of respiratory chain Complex I 1
  • Selective degeneration of dopaminergic neurons in the substantia nigra
  • Development of Lewy bodies containing neurofilament antigens 3
  • Manifests as tremor, rigidity, bradykinesia, and postural instability
  • Axial rigidity more prominent than appendicular rigidity 4

Huntington's Disease

  • Characterized by impaired activity of respiratory chain Complexes II and III 1
  • Selective vulnerability of striatal neurons
  • Genetic disorder with autosomal dominant inheritance
  • Manifests as chorea, cognitive decline, and psychiatric symptoms
  • Classified as a hyperkinetic movement disorder 1

Diagnostic Approaches

Diagnosis of these neurodegenerative diseases typically involves:

  • Clinical assessment of characteristic symptoms
  • Neuroimaging studies (MRI, PET)
  • Electroencephalographic (rsEEG) measures
  • Exclusion of other potential etiologies 1

Imaging Findings

  • MRI: Shows patterns of atrophy in disease-specific brain regions
  • FDG-PET: Reveals hypometabolism in affected brain regions
  • DaTscan (Ioflupane SPECT): Shows decreased radiotracer uptake in the striatum in Parkinsonian syndromes 4

Distinguishing Features from Other Conditions

The diseases that do NOT cause degeneration or loss of nerve cells in the brain include:

  • Sepsis
  • Chronic kidney disease
  • Scleroderma
  • Rheumatoid arthritis
  • B12 deficiency (causes demyelination but not primary neurodegeneration)
  • Myasthenia gravis (autoimmune disorder affecting neuromuscular junction)

These conditions may affect the nervous system through other mechanisms (inflammation, metabolic disturbances, autoimmune processes) but do not primarily cause progressive neurodegeneration.

Clinical Implications

Understanding the specific neurodegenerative processes is crucial for:

  • Accurate diagnosis
  • Prognosis determination
  • Development of potential disease-modifying therapies
  • Patient and family counseling

Currently, no disease-modifying treatments are available for these neurodegenerative diseases, highlighting the need for continued research into their underlying pathophysiology 4.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Progressive Supranuclear Palsy (PSP) Diagnosis and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.